163 related articles for article (PubMed ID: 2713508)
21. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma.
Portier M; Rajzbaum G; Zhang XG; Attal M; Rusalen C; Wijdenes J; Mannoni P; Maraninchi D; Piechaczyk M; Bataille R
Eur J Immunol; 1991 Jul; 21(7):1759-62. PubMed ID: 2060582
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-21 is a growth and survival factor for human myeloma cells.
Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells.
Zhang XG; Bataille R; Jourdan M; Saeland S; Banchereau J; Mannoni P; Klein B
Blood; 1990 Dec; 76(12):2599-605. PubMed ID: 2265252
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
[TBL] [Abstract][Full Text] [Related]
27. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
[TBL] [Abstract][Full Text] [Related]
28. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
30. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
31. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells.
Caux C; Moreau I; Saeland S; Banchereau J
Blood; 1992 May; 79(10):2628-35. PubMed ID: 1375107
[TBL] [Abstract][Full Text] [Related]
33. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
Kim I; Uchiyama H; Chauhan D; Anderson KC
Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein.
Urashima M; Ogata A; Chauhan D; Vidriales MB; Teoh G; Hoshi Y; Schlossman RL; DeCaprio JA; Anderson KC
Blood; 1996 Sep; 88(6):2219-27. PubMed ID: 8822942
[TBL] [Abstract][Full Text] [Related]
35. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma.
Zhang XG; Klein B; Bataille R
Blood; 1989 Jul; 74(1):11-3. PubMed ID: 2787674
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells.
Caux C; Saeland S; Favre C; Duvert V; Mannoni P; Banchereau J
Blood; 1990 Jun; 75(12):2292-8. PubMed ID: 1693526
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia.
Gualtieri RJ; Emanuel PD; Zuckerman KS; Martin G; Clark SC; Shadduck RK; Dracker RA; Akabutu J; Nitschke R; Hetherington ML
Blood; 1989 Nov; 74(7):2360-7. PubMed ID: 2679915
[TBL] [Abstract][Full Text] [Related]
39. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
Barton BE; Murphy TF
Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
